Differences in circulating microRNA signature in Prader-Willi syndrome and non-syndromic obesity

Devis Pascut, Sofia Tamini, Silvia Bresolin, Pablo Giraudi, Giuseppe Basso, Alessandro Minocci, Claudio Tiribelli, Graziano Grugni, Alessandro Sartorio

Research output: Contribution to journalArticle

Abstract

Prader-Willi syndrome (PWS) represents the most common genetic-derived obesity disorder caused by the loss of expression of genes located on the paternal chromosome 15q11.2-q13. The PWS phenotype shows peculiar physical, endocrine and metabolic characteristics compared to those observed in non-syndromic essential obesity. Since miRNAs have now a well-established role in many molecular pathways, including regulatory networks related to obesity, this pilot study was aimed to characterize the expression of circulating miRNAs in PWS compared to essential obesity. The circulating miRNome of 10 PWS and 10 obese subjects, adequately matched for age, BMI and sex, was profiled throughout Genechip miRNA 4.0 microarray analysis. We identified 362 out of 2578 mature miRNAs to be expressed in serum of the studied population. The circulating miRNA signature significantly characterising the two populations include 34 differently expressed RNAs. Among them, miR-24-3p, miR-122 and miR-23a-3p highly differ between the two groups with a FC >10 in obese compared to PWS. In the obese subjects, miR-7107-5p, miR-6880-3p, miR-6793-3p and miR-4258 were associated to the presence of steatosis. A different signature of miRNAs significantly distinguished PWS with steatosis from PWS without steatosis, involving miR-619-5p, miR-4507, miR-4656, miR-7847-3p and miR-6782-5p. The miRNA target GO enrichment analysis showed the different pathway involved in these two different forms of obesity. Although the rarity of PWS actually represents a limitation to the availability of large series, the present study provides novel hints on the molecular pathogenesis of syndromic and non-syndromic obesity.

Original languageEnglish
Pages (from-to)1262-1274
Number of pages13
JournalEndocrine Connections
Volume7
Issue number12
DOIs
Publication statusPublished - Dec 1 2018

Fingerprint

Prader-Willi Syndrome
MicroRNAs
Obesity
Microarray Analysis
Population
Chromosomes
RNA
Phenotype
Gene Expression

Cite this

Differences in circulating microRNA signature in Prader-Willi syndrome and non-syndromic obesity. / Pascut, Devis; Tamini, Sofia; Bresolin, Silvia; Giraudi, Pablo; Basso, Giuseppe; Minocci, Alessandro; Tiribelli, Claudio; Grugni, Graziano; Sartorio, Alessandro.

In: Endocrine Connections, Vol. 7, No. 12, 01.12.2018, p. 1262-1274.

Research output: Contribution to journalArticle

Pascut, Devis ; Tamini, Sofia ; Bresolin, Silvia ; Giraudi, Pablo ; Basso, Giuseppe ; Minocci, Alessandro ; Tiribelli, Claudio ; Grugni, Graziano ; Sartorio, Alessandro. / Differences in circulating microRNA signature in Prader-Willi syndrome and non-syndromic obesity. In: Endocrine Connections. 2018 ; Vol. 7, No. 12. pp. 1262-1274.
@article{e861cd54305e4781b715fcde52cecc54,
title = "Differences in circulating microRNA signature in Prader-Willi syndrome and non-syndromic obesity",
abstract = "Prader-Willi syndrome (PWS) represents the most common genetic-derived obesity disorder caused by the loss of expression of genes located on the paternal chromosome 15q11.2-q13. The PWS phenotype shows peculiar physical, endocrine and metabolic characteristics compared to those observed in non-syndromic essential obesity. Since miRNAs have now a well-established role in many molecular pathways, including regulatory networks related to obesity, this pilot study was aimed to characterize the expression of circulating miRNAs in PWS compared to essential obesity. The circulating miRNome of 10 PWS and 10 obese subjects, adequately matched for age, BMI and sex, was profiled throughout Genechip miRNA 4.0 microarray analysis. We identified 362 out of 2578 mature miRNAs to be expressed in serum of the studied population. The circulating miRNA signature significantly characterising the two populations include 34 differently expressed RNAs. Among them, miR-24-3p, miR-122 and miR-23a-3p highly differ between the two groups with a FC >10 in obese compared to PWS. In the obese subjects, miR-7107-5p, miR-6880-3p, miR-6793-3p and miR-4258 were associated to the presence of steatosis. A different signature of miRNAs significantly distinguished PWS with steatosis from PWS without steatosis, involving miR-619-5p, miR-4507, miR-4656, miR-7847-3p and miR-6782-5p. The miRNA target GO enrichment analysis showed the different pathway involved in these two different forms of obesity. Although the rarity of PWS actually represents a limitation to the availability of large series, the present study provides novel hints on the molecular pathogenesis of syndromic and non-syndromic obesity.",
author = "Devis Pascut and Sofia Tamini and Silvia Bresolin and Pablo Giraudi and Giuseppe Basso and Alessandro Minocci and Claudio Tiribelli and Graziano Grugni and Alessandro Sartorio",
year = "2018",
month = "12",
day = "1",
doi = "10.1530/EC-18-0329",
language = "English",
volume = "7",
pages = "1262--1274",
journal = "Endocrine Connections",
issn = "2049-3614",
publisher = "BioScientifica Ltd.",
number = "12",

}

TY - JOUR

T1 - Differences in circulating microRNA signature in Prader-Willi syndrome and non-syndromic obesity

AU - Pascut, Devis

AU - Tamini, Sofia

AU - Bresolin, Silvia

AU - Giraudi, Pablo

AU - Basso, Giuseppe

AU - Minocci, Alessandro

AU - Tiribelli, Claudio

AU - Grugni, Graziano

AU - Sartorio, Alessandro

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Prader-Willi syndrome (PWS) represents the most common genetic-derived obesity disorder caused by the loss of expression of genes located on the paternal chromosome 15q11.2-q13. The PWS phenotype shows peculiar physical, endocrine and metabolic characteristics compared to those observed in non-syndromic essential obesity. Since miRNAs have now a well-established role in many molecular pathways, including regulatory networks related to obesity, this pilot study was aimed to characterize the expression of circulating miRNAs in PWS compared to essential obesity. The circulating miRNome of 10 PWS and 10 obese subjects, adequately matched for age, BMI and sex, was profiled throughout Genechip miRNA 4.0 microarray analysis. We identified 362 out of 2578 mature miRNAs to be expressed in serum of the studied population. The circulating miRNA signature significantly characterising the two populations include 34 differently expressed RNAs. Among them, miR-24-3p, miR-122 and miR-23a-3p highly differ between the two groups with a FC >10 in obese compared to PWS. In the obese subjects, miR-7107-5p, miR-6880-3p, miR-6793-3p and miR-4258 were associated to the presence of steatosis. A different signature of miRNAs significantly distinguished PWS with steatosis from PWS without steatosis, involving miR-619-5p, miR-4507, miR-4656, miR-7847-3p and miR-6782-5p. The miRNA target GO enrichment analysis showed the different pathway involved in these two different forms of obesity. Although the rarity of PWS actually represents a limitation to the availability of large series, the present study provides novel hints on the molecular pathogenesis of syndromic and non-syndromic obesity.

AB - Prader-Willi syndrome (PWS) represents the most common genetic-derived obesity disorder caused by the loss of expression of genes located on the paternal chromosome 15q11.2-q13. The PWS phenotype shows peculiar physical, endocrine and metabolic characteristics compared to those observed in non-syndromic essential obesity. Since miRNAs have now a well-established role in many molecular pathways, including regulatory networks related to obesity, this pilot study was aimed to characterize the expression of circulating miRNAs in PWS compared to essential obesity. The circulating miRNome of 10 PWS and 10 obese subjects, adequately matched for age, BMI and sex, was profiled throughout Genechip miRNA 4.0 microarray analysis. We identified 362 out of 2578 mature miRNAs to be expressed in serum of the studied population. The circulating miRNA signature significantly characterising the two populations include 34 differently expressed RNAs. Among them, miR-24-3p, miR-122 and miR-23a-3p highly differ between the two groups with a FC >10 in obese compared to PWS. In the obese subjects, miR-7107-5p, miR-6880-3p, miR-6793-3p and miR-4258 were associated to the presence of steatosis. A different signature of miRNAs significantly distinguished PWS with steatosis from PWS without steatosis, involving miR-619-5p, miR-4507, miR-4656, miR-7847-3p and miR-6782-5p. The miRNA target GO enrichment analysis showed the different pathway involved in these two different forms of obesity. Although the rarity of PWS actually represents a limitation to the availability of large series, the present study provides novel hints on the molecular pathogenesis of syndromic and non-syndromic obesity.

U2 - 10.1530/EC-18-0329

DO - 10.1530/EC-18-0329

M3 - Article

C2 - 30352401

VL - 7

SP - 1262

EP - 1274

JO - Endocrine Connections

JF - Endocrine Connections

SN - 2049-3614

IS - 12

ER -